Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Patent
1993-07-22
1997-01-07
Vogel, Nancy T.
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
4353201, 4352531, C12N 121, C12N 1574
Patent
active
055916325
ABSTRACT:
The present invention relates to recombinant mycobacteria, particularly recombinant M. bovis BCG, which express heterologous DNA encoding a product (protein or polypeptide) of interest, such a protein or polypeptide (e.g., an antigen) against which an immune response is desired or a cytokine.
REFERENCES:
Duda, M. A., et al., "Secretion of IL-2 after transfection of rIL-2 gene into BCG", Proc. Amer. Assoc. Cancer Res. Ann. Meet., 34(0) (1993). 84th annual meeting, Orlando, Fl., USA, May 19-22, 1993.
O'Donnell, M. A., et al., "Construction of interleukin-2 secreting BCG", J. Urol., 149(4 suppl.):270A (1993). 88th annual meeting of the Am. Urol. Soc., San Antonio, TX, May 15-20, 1993.
O'Donnell, M. A., "Recombinant Mycobacterium bovis BCG Secreting Functional Interleukin-2 Enhances Gamma Interferon Production by Splenocytes", Infect. Immun. 62(6):2508-2514 (Jun. 1994).
Aldovini, A. and Young, R. A., "Humoral and cell mediated immune responses to live recombinant BCG-HIV vaccines", Nature 351:479-484 (1991).
T. Ramakrishnan and M. S. Shaila, Interfamilial Transfer of Amber Suppressor Gene for the Isolation of Amber Mutants of Mycobacteriophage I3, (1979) Arch. Microbiol., 120:301-302.
Inoue, T. et al., "Early appearing .gamma./.delta.Bearing T cells during infection with Calmette Guerin Bacillus," J. Immunol., 146:2754-2762 (1991).
Matsuo, K. et al., "Cloning and expression of the mycobacterium bovis BCG gene for the extracellular alpha antigen," J. Bacter., 170:3847-3854 (1988).
Matsuo, K. et al., "Establishment of a foreign antigen secretion system in mycobacteria," Infect. Immun., 58:4049-4054 (1990).
Carrier, M. J. et al., "Expression of Human IL-1 .beta. in Salmonella typhonuorium. A model system for the delivery of recombinant therapeutic proteins in vivo," J. Immunol., 148:1176-1781 (1992).
Ramshaw, I. et al., "Expression of cytokines by recombinant vaccinia viruses: A model for studying cytokines in virus infections in vivo," Immunol. Rev., 127:157-182 (1992).
Huygen, K., et al., "Spleen cell cytokine secretion in Mycobacterium bovis BCG-Infected Mice," Infect. Immun., 60:2880-2886 (1992).
Ratliff, T. L., et al., "Requirement of a thymus dependent immune response for BCG-mediated antitumor activity," J. Urol, 137:155-158 (1987).
Sasaki, H., et al., "Induction of interleukin-3 and tumor resistance by SSM, a cancer immunotherapeutic agent extracted from Mycobacterium tuberculosis," Cancer Res., 50:4032-4037 (1990).
Wallis, R. S., et al., "Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot," Proc. Natl. Acad. Sci., 87:3348-3352 (1990).
Wolfe, S. A., et al., "Induction of `natural killer` cells by BCG," Nature, 262:584-586 (1976).
Yamamura, M., et al., "Defining protective responses to pathogens: cytokine profiles in leprosy lesions," Science, 254:277-279 (1991).
Heinzel, F. P., et al., "Reciprocal expression of interferon-.gamma. or interleukin-4 during resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subset," J. Exp. Med, 169:59-72 (1989).
Prescott, S., et al., "Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall," J. Urol., 147:1636-1642 (1992).
Born, W., et al., "Recognition of heat shock proteins and .gamma..delta. cell function," Immunol. Today, 11:40-43 (1990).
Boom, W. H. et al., "Human mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes," Infect. and Immun, 59:2737-2743 (1991).
Del Prete, G. F., et al., "Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production," J. Clin. Invest., 88:346-350 (1991).
Burke et al, EMBO J., 3(11):2549-2554 (1984).
Lindquist et al, Ann. Rev. Genet., 22 631-677 (1988).
Lathigra et al., Nucl. Acid. Res., 16(4):1636 (1988).
Thole et al., Inf. and Imm., 55(6):1466-1475 (1987).
Labidi et al., FEMS Microbiol. Lett. 30:221-225 (1985).
Labidi et al, Ann. Inst. Pasteur/Microbiol., 136B:209-215 (1985).
Jacobs et al, Nature, 327:532-535 (1987).
Norgard et al, J. Bacteriol., 133(2) 1254-1262 (1978).
Aldovini Anna
DeWolf William C.
Duda Rosemary B.
O'Donnell Michael A.
Young Richard A.
Beth Israel Hospital
Vogel Nancy T.
Whitehead Institute for Biomedical Research
LandOfFree
Recombinant BCG does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant BCG, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant BCG will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1763550